Legault Pierre

Legault Pierre is listed in filings as Director at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2026, including 4 public disclosures. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX) and Bicycle Therapeutics plc (BCYC). The current snapshot covers public activity from Jan 6, 2025 to Feb 6, 2026. Reported amounts are shown as $350.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.